title: Sanofi’s successful Phase 3 trials may lead to first-ever dengue vaccine in 2015.
mesh_terms: D000293:Adolescent; D001208:Asia; D002648:Child; D017326:Clinical Trials, Phase III as Topic; D003715:Dengue / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology*; D006801:Humans; D007843:Latin America
chemical_list: D053059:Dengue Vaccines